Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study is as an extension study of SD-004-0765, to assess the safety profile of long-term
use of budesonide inhalation suspension in Japanese young children with bronchial asthma.
Children completing study SD-004-0765 continued administration of budesonide inhalation
suspension as judged by the investigator; the dose is adjusted as appropriate within the
range of 0.25 to 1.0 mg per day administered once or twice daily, according to the symptoms.